Education
About Us
Working with TipRanks
Follow Us
Azenta (AZTA)
NASDAQ:AZTA
AZTA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.91 - $63.58
Previous CloseN/A
Volume88.55K
Average Volume (3M)881.02K
Market Cap
$1.58B
Enterprise Value$1.26B
Total Cash (Recent Filing)$328.34M
Total Debt (Recent Filing)$53.70M
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Aug 05, 2025EPS Estimate
0.14Last Dividend Ex-Date
Dec 02, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding45,779,945
10 Day Avg. Volume593,176
30 Day Avg. Volume881,017
Financial Highlights & Ratios
PEG Ratio-0.42
Price to Book (P/B)0.86
Price to Sales (P/S)0.00
P/FCF Ratio56.40
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue0.49
Enterprise Value/Gross Profit4.62
Enterprise Value/Ebitda20.59
Forecast
1Y Price Target
$35.00Price Target Upside1.51% Upside
Rating ConsensusHold
Number of Analyst Covering4
Azenta News
PremiumCompany Announcements
Azenta Announces Resignation of Chief Accounting Officer
PremiumCompany Announcements
Azenta Announces Leadership Change with New General Counsel
PremiumCompany Announcements
Azenta, Inc. Reports Solid Q2 2025 Revenue Growth
PremiumCompany Announcements
Azenta, Inc. Reports Strong Q2 2025 Earnings
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAZTA’s F2Q25 revenue and EBITDA both beat consensus and management maintained its FY25 guidance.
Growth StrategyThe planned divestiture of the underperforming B Medical segment is expected to be a key catalyst for improving the stock's performance.
Strategic PartnershipsA new partnership in cell and gene therapy expands Azenta's business portfolio and enhances growth opportunities.
Bears Say
Funding ConcernsUncertainties around NIH funding and trade tensions with China are significant concerns for investors due to Azenta's exposure in the multiomics segment.
Geopolitical RisksChina is expected to remain a double-edged sword that could keep Azenta at a higher risk of exposure if geopolitical tensions continue.
Market ValuationThe price target is lowered to $40 due to lower peer multiples.
Ownership Overview
11.51% Insiders
34.65% Mutual Funds
0.15% Other Institutional Investors
22.67% Public Companies and
Individual Investors
AZTA FAQ
What was Azenta’s price range in the past 12 months?
Azenta lowest stock price was $23.91 and its highest was $63.58 in the past 12 months.
What is Azenta’s market cap?
Azenta’s market cap is $1.58B.
When is Azenta’s upcoming earnings report date?
Azenta’s upcoming earnings report date is Aug 05, 2025 which is in 11 days.
How were Azenta’s earnings last quarter?
Azenta released its earnings results on May 07, 2025. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.07 by -$0.02.
Is Azenta overvalued?
According to Wall Street analysts Azenta’s price is currently Undervalued.
Does Azenta pay dividends?
Azenta pays a Quarterly dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Azenta dividends here
What is Azenta’s EPS estimate?
Azenta’s EPS estimate is 0.14.
How many shares outstanding does Azenta have?
Azenta has 45,779,945 shares outstanding.
What happened to Azenta’s price movement after its last earnings report?
Azenta reported an EPS of $0.05 in its last earnings report, missing expectations of $0.07. Following the earnings report the stock price went down -0.629%.
Which hedge fund is a major shareholder of Azenta?
Currently, no hedge funds are holding shares in AZTA
Azenta Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$35.00 (1.51% Upside)
$35.00 (1.51% Upside)
Hedge Fund Trend
Decreased
By 45.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 3.9%
Last 30 Days ▼ 7.1%
Last 30 Days ▼ 7.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.60%
12-Months-Change
Fundamentals
Return on Equity
-2.00%
Trailing 12-Months
Asset Growth
-20.35%
Trailing 12-Months
Company Description
Azenta
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
AZTA Company Deck
AZTA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a strong performance by Azenta, with significant organic revenue growth and margin expansion. However, challenges such as declines in specific revenue streams and macroeconomic uncertainties present ongoing risks.Read More>AZTA Stock 12 Month Forecast
Average Price Target
$35.00
▲(1.51%Upside)